Hera Fertility has introduced a new model for male fertility testing that connects men directly with top CLIA-certified laboratories across the United States and Canada — bypassing the traditional referral pathway that requires a primary care visit, specialist appointment, and weeks of waiting before a man can access a semen analysis or sperm health assessment. The platform gives men who want answers about their reproductive health a direct, faster route to the same laboratory-grade testing available through fertility clinics.
The standard clinical pathway for male fertility testing has historically placed significant barriers between a man and a result. A referral from a primary care physician, a specialist consultation, and an available clinic appointment are typically required before a semen analysis is ordered — a sequence that research indicates causes many men to delay or abandon the evaluation process entirely. Semen Analysis Without a Doctor is no longer an abstract concept for men across North America — Hera Fertility has made it a practical reality by curating a network of accredited laboratory partners and giving men direct booking access without a prescription or referral requirement.
Male factor infertility contributes to an estimated 40 to 50 percent of all cases where couples experience difficulty conceiving. Despite that statistical reality, men are consistently evaluated last in a fertility workup — often after months of female-focused diagnostics have been completed. The consequence of that diagnostic gap is delayed treatment, prolonged uncertainty for couples, and fertility interventions that could have been better targeted had male testing been completed earlier in the process.
"Male fertility testing has been treated as an afterthought in reproductive healthcare for too long," said Thiv Paramsothy, CEO of Hera Fertility. "Men deserve faster access to accurate information about their reproductive health. Our platform removes the administrative barriers that have historically stood between a man and a straightforward laboratory test — and connects him with the best labs available in his area."
Hera Fertility's network spans 39 cities across the United States, Toronto, and Vancouver, with each laboratory partner holding CLIA certification — the federal standard for clinical laboratory quality in the United States that ensures analytical accuracy, quality control, and technician proficiency across all specimen types. Men searching for semen analysis near me can identify available laboratory locations, review testing options, and book directly through the platform without navigating a clinical referral system.
The standard semen analysis available through Hera Fertility's laboratory network covers sperm count, motility, morphology, and volume — the four parameters that form the foundation of any male fertility assessment. For men whose results indicate further investigation is warranted, the platform also provides access to a DNA fragmentation test — an assessment of sperm DNA integrity that standard semen analysis does not capture and that clinical research has linked to unexplained infertility and recurrent pregnancy loss in otherwise healthy couples.
Men evaluating the reliability of different male fertility testing options can review Hera Fertility's published resource on sperm test accuracy, which outlines the specific differences between consumer-grade screening devices and CLIA-certified laboratory analysis across the parameters that matter most in a clinical fertility assessment — including sperm count methodology, motility measurement precision, and morphology classification standards.
Hera Fertility was founded in 2023 to address a critical gap in men's reproductive healthcare access. The company is backed by Techstars and was selected for the Mayo Clinic Platform_Accelerate program in April 2026, providing access to Mayo Clinic's clinical data infrastructure to further develop and validate its AI-powered fertility assessment models. The platform operates across 39 cities in the United States and two Canadian cities, with laboratory network expansion ongoing.
ABOUT HERA FERTILITY:
Hera Fertility is a male reproductive health platform that connects men with top CLIA-certified laboratories for semen analysis, DNA fragmentation testing, and sperm health assessment without requiring a doctor referral or clinic appointment. Founded in 2023 and backed by Techstars, the company serves men across 39 US cities, Toronto, and Vancouver, and was selected for the Mayo Clinic Platform_Accelerate program in April 2026.
###
Contact:
Hera Fertility
1178 Broadway, 3rd Floor, 3092
New York, NY 10001
(409) 797-6846
https://herafertility.co/
[email protected]
Facebook: www.facebook.com/herafertillity/
Instagram: www.instagram.com/herafertility
YouTube: www.youtube.com/@HeraFertility
LinkedIn: www.linkedin.com/company/herafertility
Disclaimer: This press release is provided for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Individuals concerned about fertility should consult a qualified healthcare professional. The information presented is not intended to replace professional medical evaluation or individualized clinical guidance. Product availability and regulatory status may vary by jurisdiction.
Source: 38 Digital Market News
Release ID: 2612957
